Calypso Biotech

Calypso Biotech is the third spin-off company from the EPP Fund. The company is developing antibody therapeutics against niche gastro-intestinal immune disorders, such as refractory celiac disease and Crohn`s Disease. Calypso Biotech is based in Geneva, Switzerland.

http://www.calypsobiotech.com

Team Members
more about
Jasper Bos
more about
Bram Vanparys